I began taking prescribed medication to control my cystic fibrosis-related pain. Soon, the medication tried to control me.
Site Search
Showing 21 - 24 of 24 results
On my first international trip, I found myself in an interrogation room explaining my port to security officers.
Clayton Pickering
The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
News
|
|
1 min read
Vascular access devices, or PICCs and ports, allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics.
18 min read